Can’t spot what you need in our catalog? Fret not–just sign up for our expert consultations. We will provide the insights you need. We're here to guide you to your clinic's potential; no product browsing needed
ORENCIA® (abatacept) is a leading treatment for autoimmune diseases such as rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), and psoriatic arthritis (PsA). Before healthcare professionals decide to buy ORENCIA®, they must get to know how it works and what distinguishes it from other treatments on the market.
ORENCIA® works by selectively modulating the immune system and specifically targeting and inhibiting T-cell activation. This is a critical early step in the autoimmune response that leads to inflammation and joint damage. This targeted approach helps treat symptoms while slowing disease progression.
It’s available in both intravenous (IV) and subcutaneous (SC) formulations. This makes it ideal for patients who have not responded adequately to traditional disease-modifying antirheumatic drugs.
ORENCIA® is used in medical practice for treating several autoimmune conditions related to bones and joint health. This medication is indicated for moderate to severe rheumatoid arthritis (RA). Medical professionals who decide to buy ORENCIA® online can contact our team to get valid information.
This is also used in treating juvenile idiopathic arthritis (JIA) in patients who are two years and older. Doctors use ORENCIA® for treating patients who suffer from psoriatic arthritis (PsA). The therapy works by reducing their symptoms and inhibiting the progression of joint damage.
The treatment targets T-cell activation which leads to reduced inflammation, slowing disease progression, and improving physical function.
Clinics typically buy ORENCIA® wholesale to use it as part of a long-term plan for patients suffering from severe rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis. And the onset of ORENCIA®’s therapeutic effects is different for every patient. However, there are clinical studies that show some patients’ symptoms improve within the first few weeks of treatment.
More significant benefits from the treatment, such as reduced inflammation and improved joint function, may take up to three to six months of consistent application to manifest fully. In case patients suddenly stop taking ORENCIA®, the symptoms can appear again.
Even though ORENCIA® can significantly help improve symptoms in patients suffering from RA, JIA, and PsA, it’s not without side effects. Doctors looking to buy ORENCIA® online for their practice should be aware of all these aftereffects.
Patients who are using ORENCIA® most commonly report symptoms like headache, upper respiratory infections, nausea, and injection site reactions for those choosing subcutaneous (SC) administration.
However, there are some more serious risks doctors should consider:
There are two primary administration techniques of ORENCIA®, intravenous (IV) infusions and subcutaneous (SC) injections. This makes it suitable for different patient’s needs. Healthcare practitioners should buy ORENCIA® online from reputable sources to ensure maximum patient safety before the administration.
When applied in IV form, the monthly injection should be performed in a clinical setting by a medical professional. The administration itself lasts typically around 30 minutes. The initial doses are given at zero, two, and four weeks followed by monthly maintenance doses. Patients should be monitored during and after the infusion for any adverse reactions.
Patients opting for the SC injection should receive proper training from professionals on how to self-administer ORENCIA® correctly. This includes instructions on aseptic technique, site rotation, and how to handle the prefilled syringes or autoinjectors.
Clinics looking to buy ORENCIA® wholesale for patients suffering from RA, JIA, and PsA will not make a mistake by choosing this brand. There are some competitors in the market, such as Humira® (adalimumab) and Actemra® (tocilizumab). But ORENCIA® targets the T-cell activation pathway.
This gives it an advantage for patients who may not respond adequately to treatments focusing on other pathways of the immune response.
As a TNF inhibitor, Humira® is used in the remedying of RA, JIA, PsA, and other inflammatory conditions. It works by blocking tumor necrosis factors, but patients with a history of serious infections or heart failure may need to approach TNF inhibitors with caution.
Actemra® (tocilizumab) is an IL-6 receptor blocker used in the management of moderate to severe RA and systemic JIA. It works by inhibiting the interleukin-6 (IL-6) pathway. But its potential risks include liver enzyme elevations, neutropenia, and the possibility of serious infections.
ORENCIA® is available for purchase through authorized pharmaceutical distributors and specialty pharmacies. We encourage healthcare professionals to contact our team to get more information on where to find a genuine product. Our experts are ready to assist you with purchasing options and support.